NASDAQ
Orchestra BioMed Holdings, Inc. (OBIO) has a free cash flow growth of -870.56% as of Friday, May 29, 2026. This represents a 4845.50% decrease compared to its 12-month average of 18.34%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.